The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer. Long-term follow-up results of a randomised trial.

Br J Cancer · 1992 · PMC1978025 · PMID 1457360

Europe PMC DOI

hedged sentence

0.0040

closest p · 0.1× alpha

0.0040

boldest claim

The sentences

highly significantP = 0.004actually significant

There was a better relapse-free survival in the groups receiving chemotherapy compared to radiotherapy alone (P = 0.05), which was highly significant in a multivariate Cox analysis (P = 0.004).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.